In re Cardizem CD Antitrust Litigation (Per Se Rule in Drug Patent Case)

AAI files brief in 6th Circuit’s hearing on Cardizem appeal, urging approval of District Court’s holding that agreement by patent holder to pay generic to stay out of market is per se violation.

The brief is available here in Adobe Acrobat format.